Home › Metastatic Cancer › California › Mountain View
Metastatic Cancer clinical trials in Mountain View, CA
25 studies for Metastatic Cancer are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi away
- VA Palo Alto Health Care System, Palo Alto · 5 mi away
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
RecruitingPhase 1/2
- Stanford, Palo Alto · 5 mi away
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- Stanford Cancer Center, Palo Alto · 5 mi away
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Palo Alto Medical Foundation - Palo Alto Center, Palo Alto · 5 mi away
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
RecruitingPhase 1/2
- Stanford Medicine, Palo Alto · 5 mi away
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
RecruitingPhase 1
- Stanford Cancer Institute, Stanford · 5 mi away
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RecruitingPhase 1
- Stanford University Medical Center, Stanford · 5 mi away
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecruitingPhase 3
- Stanford Women's Cancer Center, Palo Alto · 5 mi away
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecruitingPhase 3
- Stanford Cancer Center, Palo Alto · 5 mi away
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- Stanford Cancer Institute, Stanford · 5 mi away
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
RecruitingPhase 2
- Stanford University, Palo Alto · 5 mi away
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RecruitingPhase 3
- Research Site, Palo Alto · 5 mi away
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
RecruitingPhase 1/2
- Stanford Cancer Institute (SCI), Stanford · 5 mi away
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RecruitingPhase 1
- Stanford Medicine Cancer Center, Stanford · 5 mi away
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mi away
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
RecruitingPhase 3
- Stanford University School of Medicine, Palo Alto · 5 mi away
A Study of LY4175408 in Participants With Advanced Cancer
RecruitingPhase 1
- Stanford Medicine Cancer Center, Stanford · 5 mi away
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
RecruitingPhase 1/2
- Stanford Cancer Institute, Stanford · 5 mi away
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
RecruitingPhase 2/3
- Stanford Health Care - Skin Cancer Program, Stanford · 5 mi away
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RecruitingPhase 2/3
- Stanford Cancer Institute, Palo Alto · 5 mi away
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RecruitingPhase 1
- Stanford Cancer Institute, Stanford · 5 mi away
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
RecruitingPhase 1
- Stanford Cancer Institute, Stanford · 5 mi away
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
RecruitingObservational study
- VA Palo Alto Healthcare System, Palo Alto · 5 mi away
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
RecruitingPhase 1
- Stanford Cancer Institute, Palo Alto · 5 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Stanford · 5 mi away
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Mountain View
- Cancer (all types)40 studies
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Ovarian Cancer19 studies
- Autism Spectrum Disorder17 studies
- Lung Cancer17 studies
- Prostate Cancer15 studies
- Heart Failure15 studies
- Autism13 studies
- Acute Lymphoblastic Leukemia13 studies
- Colorectal Cancer13 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.